Detecting myocardial ischemia at rest with cardiac phase-resolved blood oxygen level-dependent cardiovascular

Sotirios A Tsaftaris1, Xiangzhi Zhou, Richard Tang

  • 1Departments of Radiology, Northwestern University, Chicago, IL, USA.

Insights

Cardiac phase-resolved blood oxygen level-dependent (CP-BOLD) cardiovascular magnetic resonance effectively detects myocardial ischemia at rest. This technique shows promise for managing severe coronary artery disease before tissue damage occurs.

Area of Science:

  • Cardiovascular Imaging
  • Biomedical Engineering
  • Diagnostic Medicine

Background:

  • Early detection of myocardial ischemia is crucial for managing severe coronary artery disease.
  • Noninvasive methods are needed to identify ischemic territories and assess cardiac function before irreversible tissue changes.
  • Cardiac phase-resolved blood oxygen level-dependent (CP-BOLD) cardiovascular magnetic resonance is explored for its potential in diagnosing resting ischemia.

Purpose of the Study:

  • To investigate the efficacy of CP-BOLD cardiovascular magnetic resonance in detecting myocardial ischemia at rest.
  • To assess the ability of CP-BOLD to identify ischemic regions secondary to severe coronary artery stenosis.
  • To compare CP-BOLD's diagnostic performance with standard cine imaging and functional assessments.

Main Methods:

  • CP-BOLD, standard cine, and T2-weighted MRI sequences were acquired in canines at baseline and during induced ischemia.
  • Myocardial segments were analyzed for systolic-to-diastolic (S/D) signal intensity ratios using CP-BOLD and cine images.
  • Affected and remote myocardial regions were identified using late-gadolinium-enhancement imaging post-reperfusion.

Main Results:

  • CP-BOLD demonstrated a significant decrease in the S/D ratio in ischemic myocardial territories during rest, a change not observed in standard cine images.
  • The S/D ratio derived from CP-BOLD accurately identified affected regions, with an area under the curve of 0.87 in receiver-operating characteristic analysis.
  • CP-BOLD derived ejection fraction and segmental wall thickening also showed diagnostic capability, comparable to the S/D ratio.

Conclusions:

  • Preclinical findings suggest CP-BOLD cardiovascular magnetic resonance is a viable tool for detecting myocardial ischemia at rest.
  • The study highlights CP-BOLD's potential for early diagnosis in severe coronary artery disease management.
  • Further clinical studies are warranted to validate these findings in human patients.
Abstract